Innovita Biological Technology Future Growth
Future criteria checks 6/6
Innovita Biological Technology is forecast to grow earnings and revenue by 32.4% and 29.9% per annum respectively. EPS is expected to grow by 32.4% per annum. Return on equity is forecast to be 24% in 3 years.
Key information
32.4%
Earnings growth rate
32.4%
EPS growth rate
| Medical Equipment earnings growth | 26.5% |
| Revenue growth rate | 29.9% |
| Future return on equity | 24.0% |
| Analyst coverage | Low |
| Last updated | 27 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,457 | 706 | N/A | 696 | 1 |
| 12/31/2025 | 1,136 | 532 | N/A | 533 | 1 |
| 12/31/2024 | 874 | 400 | N/A | 399 | 1 |
| 9/30/2024 | 720 | 332 | 406 | 433 | N/A |
| 6/30/2024 | 676 | 303 | 384 | 409 | N/A |
| 3/31/2024 | 625 | 266 | 390 | 413 | N/A |
| 12/31/2023 | 478 | 174 | 243 | 260 | N/A |
| 9/30/2023 | 415 | 110 | 90 | 126 | N/A |
| 6/30/2023 | 420 | 120 | 46 | 91 | N/A |
| 3/31/2023 | 512 | 178 | 27 | 85 | N/A |
| 12/31/2022 | 447 | 151 | 69 | 126 | N/A |
| 9/30/2022 | 373 | 143 | 62 | 100 | N/A |
| 6/30/2022 | 360 | 133 | 64 | 100 | N/A |
| 3/31/2022 | 267 | 78 | 48 | 87 | N/A |
| 12/31/2021 | 327 | 120 | 43 | 106 | N/A |
| 12/31/2020 | 1,037 | 571 | 563 | 640 | N/A |
| 12/31/2019 | 138 | 21 | 25 | 35 | N/A |
| 12/31/2018 | 79 | 17 | 8 | 13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688253's forecast earnings growth (32.4% per year) is above the savings rate (2.8%).
Earnings vs Market: 688253's earnings (32.4% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 688253's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688253's revenue (29.9% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 688253's revenue (29.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688253's Return on Equity is forecast to be high in 3 years time (24%)